Proteomics, Metabolomics and Lipidomics News and Research

Latest Proteomics, Metabolomics and Lipidomics News and Research

Protein's 'silent code' influences cell movement

Protein's 'silent code' influences cell movement

The protein actin is ubiquitous and essential for life. In mammals, every cell expresses two of its forms, beta-actin and gamma-nonmuscle-actin. Despite having distinct roles, the two forms are nearly identical, sharing 99% of their amino acid sequence.

8 Jul 2021

New protein plays a critical "go, or no-go" role in germination

New protein plays a critical "go, or no-go" role in germination

Dehydrated plant seeds can lay dormant for long periods--over 1,000 years in some species--before the availability of water can trigger germination. This protects the embryonic plant inside from a variety of environmental stresses until conditions are favorable for growth and survival.

8 Jul 2021

Meat and meat-based substitutes vary widely in their nutritional content

Meat and meat-based substitutes vary widely in their nutritional content

Plant-based meats are similar to real beef in their taste, along with the 13 nutritional items listed on their labels making them appear equivalent to meat.

8 Jul 2021

Lipidomics study reveals schizophrenic patients’ resistance to antipsychotic drugs

Lipidomics study reveals schizophrenic patients’ resistance to antipsychotic drugs

Scientists discovered 22 lipids in the blood plasma of schizophrenia patients that were linked to slower symptom improvement over time.

8 Jul 2021

New method for generating metabolic profiles of individual cells

New method for generating metabolic profiles of individual cells

Researchers from the EMBL and the German Cancer Research Center (DKFZ) demonstrated a new technique to create metabolic profiles of individual cells.

8 Jul 2021

Study identifies the gene responsible for toxic vicine and convicine production in faba beans

Study identifies the gene responsible for toxic vicine and convicine production in faba beans

Faba beans have been a good source of protein. A team of experts has now found the gene that causes the toxic vicine and convicine to be produced.

7 Jul 2021

Nanobody mapping using NMR proves a promising alternative for therapeutic use

Nanobody mapping using NMR proves a promising alternative for therapeutic use

Researchers used NMR techniques to determine the structure of a nanobody, facilitating a better understanding of how the protein fights against diseases.

6 Jul 2021

CRISPR-Cas9 system could help perform very effective target gene silencing

CRISPR-Cas9 system could help perform very effective target gene silencing

CRISPR-Cas9's extraordinary ability to modify specific areas of DNA has made it a favorite among gene-editing tools for researchers.

6 Jul 2021

Kinetochore modeling could help create artificial chromosomes

Kinetochore modeling could help create artificial chromosomes

Mitosis, the mechanism of cell division, is an age-old process. Yet, the process has not been fully understood or replicated.

5 Jul 2021

Neurodevelopmental disorders may be caused by a new genetic variation in a single gene

Neurodevelopmental disorders may be caused by a new genetic variation in a single gene

Genetic variations of a neuro-associated gene termed SPTBN1 have been revealed to cause a neurodevelopmental disorder, according to researchers.

5 Jul 2021

New technique can edit plant chloroplasts without leaving any heritable changes

New technique can edit plant chloroplasts without leaving any heritable changes

Geneticists at the University of Tokyo have developed a new gene-editing technique that modifies the chloroplast of plant cells.

2 Jul 2021

New study maps the evolutionary history and interrelationships of protein domains

New study maps the evolutionary history and interrelationships of protein domains

Since the start of the COVID-19 epidemic, proteins have been stealthily taking over human lives.

2 Jul 2021

New method can improve the efficacy of promising treatment for recurrent glioblastoma

New method can improve the efficacy of promising treatment for recurrent glioblastoma

A promising treatment for melanoma and other types of cancers is neoadjuvant immune checkpoint blockade (ICB).

1 Jul 2021

Mutations on SARS-CoV-2 spike proteins create antibody-resistant variants

Mutations on SARS-CoV-2 spike proteins create antibody-resistant variants

Researchers have identified how mutations on the SARS-CoV-2 spike protein separately create variants that are potentially resistant to antibodies.

1 Jul 2021

Novel mechanism helps barley growers attain high yields at high temperature

Novel mechanism helps barley growers attain high yields at high temperature

An international team of researchers has identified a novel mechanism in barley plants, which could help crop growers achieve high yields as temperatures rise.

30 Jun 2021

Researchers profile lysosomes based on single metabonomic information

For the first time, researchers have achieved lysosome typing based on single lysosome metabonomic data.

30 Jun 2021

Study reveals how plants store energy in the thylakoid membrane

Study reveals how plants store energy in the thylakoid membrane

A new computer model could help better understand how plants store energy in the thylakoid membrane, a fundamental component in photosynthesis.

30 Jun 2021

Determining class A drug use from a single fingerprint

Determining class A drug use from a single fingerprint

AZoLifeSciences speaks to Dr. Catia Costa about her latest research that showed how class A drug use can be determined from a single fingerprint.

From University of Surrey 29 Jun 2021

Specific chemical feature of a key protein may lead to neurodegenerative diseases

Specific chemical feature of a key protein may lead to neurodegenerative diseases

Scientists have found that a particular chemical feature of a crucial protein may cause it to build up in the brain and lead to various disorders.

28 Jun 2021

WEHI partners with Boehringer Ingelheim to develop novel anti-cancer therapeutics

WEHI partners with Boehringer Ingelheim to develop novel anti-cancer therapeutics

WEHI has partnered with Boehringer Ingelheim, a leading research-driven pharmaceutical company, in a collaboration to discover and develop anti-cancer therapeutics using a promising new technology called targeted protein degradation.

From Walter and Eliza Hall Institute of Medical Research (WEHI) 25 Jun 2021

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.